Caricamento...
Development of Novel Radiosensitizers through the National Cancer Institute’s Small Business Innovation Research Program
While radiosensitizing chemotherapy has improved survival for several types of cancer, current chemoradiation regimens remain ineffective for many patients and have substantial toxicities. Given the strong need for the development of novel radiosensitizers to further improve patient outcomes, the Ra...
Salvato in:
| Pubblicato in: | Radiat Res |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7266046/ https://ncbi.nlm.nih.gov/pubmed/32216707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1667/RR15545.1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|